Alemtuzumab

Alemtuzumab is an approved monoclonal antibody injection that is used to treat certain types of cancer, most notably leukemia and lymphoma. It works by targeting and binding to a specific surface antigen that is found on cancer cells, which then triggers the immune system to attack and destroy them. Alemtuzumab has demonstrated its efficacy in both chemotherapy and stem cell transplants, and offers a highly effective treatment for people suffering from these types of cancer. Additionally, it has also been found to be effective in treating several autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, and lupus, by suppressing the activity of certain cells in the body’s immune system. As such, alemtuzumab provides an important option for many individuals suffering from serious illnesses.